<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title>Frontiers in Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnins.2023.1344915</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Smieszek</surname> <given-names>Sandra P.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1124775/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kaden</surname> <given-names>Alyssa R.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Johnson</surname> <given-names>Caroline E.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Brzezynski</surname> <given-names>Jennifer L.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Xiao</surname> <given-names>Changfu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Polymeropoulos</surname> <given-names>Christos M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Birznieks</surname> <given-names>Gunther</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Emsellem</surname> <given-names>Helene A.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Polymeropoulos</surname> <given-names>Mihael H.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Vanda Pharmaceuticals Inc.</institution>, <addr-line>Washington, DC</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>The Center for Sleep &#x00026; Wake Disorders</institution>, <addr-line>Chevy Chase, MD</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Neurology, George Washington University</institution>, <addr-line>Washington, DC</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited and reviewed by: Melissa A. St. Hilaire, Merrimack College, United States</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Sandra P. Smieszek <email>sandra.smieszek&#x00040;vandapharma.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>17</volume>
<elocation-id>1344915</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>11</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>12</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2024 Smieszek, Kaden, Johnson, Brzezynski, Xiao, Polymeropoulos, Birznieks, Emsellem and Polymeropoulos.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Smieszek, Kaden, Johnson, Brzezynski, Xiao, Polymeropoulos, Birznieks, Emsellem and Polymeropoulos</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Neurosci." journal-id-type="nlm-ta" vol="17" page="1287514" xlink:href="10.3389/fnins.2023.1287514" ext-link-type="doi">A corrigendum on <article-title>Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study</article-title> by Smieszek, S. P., Kaden, A. R., Johnson, C. E., Brzezynski, J. L., Xiao, C., Polymeropoulos, C. M., Birznieks, G., Emsellem, H. A., and Polymeropoulos, M. H. (2023). <italic>Front. Neurosci</italic>. 17:1287514. doi: <object-id>10.3389/fnins.2023.1287514</object-id></related-article>
<kwd-group>
<kwd>biological rhythms</kwd>
<kwd>circadian rhythm disorders</kwd>
<kwd>clinical trials research</kwd>
<kwd>sleep/wake mechanisms</kwd>
<kwd>Delayed Sleep-Wake Phase Disorder</kwd>
<kwd>delayed sleep</kwd>
<kwd>night owl</kwd>
<kwd>Optic Nerve Hypoplasia</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="1"/>
<page-count count="2"/>
<word-count count="621"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Sleep and Circadian Rhythms</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In the published article, there was an error. (There was an omission).</p>
<p>A correction has been made to <bold>Discussion</bold>, Paragraph 4. This sentence previously stated:</p>
<p>&#x0201C;This participant is not a carrier of the variable number of tandem repeat (VNTR) <italic>PER</italic>3<sup>4/4</sup> genotype, associated with delayed sleep patterns, nor the <italic>CRY1</italic> splicing variant (Patke et al., <xref ref-type="bibr" rid="B1">2017</xref>). No other predicted loss-of-function mutations within circadian genes were identified.&#x0201D;</p>
<p>The corrected sentence appears below:</p>
<p>&#x0201C;This participant is not a carrier of the variable number of tandem repeat (VNTR) <italic>PER</italic>3<sup>4/4</sup> genotype, associated with delayed sleep patterns, nor the <italic>CRY1</italic> splicing variant (Patke et al., <xref ref-type="bibr" rid="B1">2017</xref>). This patient has been determined to carry two 5&#x02032; UTR region variants in the Atonal BHLH Transcription Factor 7 (ATOH7) gene known to be associated with ONH, rs61854782 and rs7916697. ATOH7 is expressed in retinal progenitor cells and has a crucial role in retinal ganglion cell development. No other predicted loss-of-function mutations within circadian genes were identified.&#x0201D;</p>
<p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
<back>
<sec sec-type="disclaimer" id="s1">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patke</surname> <given-names>A.</given-names></name> <name><surname>Murphy</surname> <given-names>P.</given-names></name> <name><surname>Onat</surname> <given-names>O.</given-names></name> <name><surname>Krieger</surname> <given-names>A.</given-names></name> <name><surname>&#x000D6;z&#x000E7;elik</surname> <given-names>T.</given-names></name> <name><surname>Campbell</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Mutation of the human circadian clock gene CRY1 in familial delayed sleep phase disorder</article-title>. <source>Cell</source> <volume>169</volume>, <fpage>203</fpage>&#x02013;<lpage>215</lpage>.e1. <pub-id pub-id-type="doi">10.1016/j.cell.2017.03.027</pub-id><pub-id pub-id-type="pmid">28388406</pub-id></citation></ref>
</ref-list>
</back>
</article>